Friday May 19, 2017
International Health Community Rejects TPP Revival in Open Letter to Trade Ministers meeting in Hanoi
Prominent public health, advocacy and professional organisations have called on trade ministers from eleven remaining
Trans-Pacific Partnership countries not to attempt to resurrect the deal at their meeting in Hanoi tomorrow.
The open letter (full text below) is signed by the World Federation of Public Health Organisations and leading health organisations from most of the
non-US participating countries - including from Australia, New Zealand and Japan, whose governments are leading moves to
revive the agreement since the U.S. withdrawal.
The signatories reiterated concerns they and others had previously raised regarding the negative impacts of the
Agreement on people’s right to health, access to affordable medicines, and the ability of governments to regulate
health-damaging activities of corporations.
Many of these provisions were included at the insistence of the U.S., which is no longer party, notably the
unprecedented monopoly protections for biologic medicines.
To address their concerns many parts of the text signed on 4 February 2016 would have to be rewritten from first
"The provisions for biologic medicines included in the TPP at the behest of the U.S. pharmaceutical industry would
reduce access to treatments for cancer and other serious health conditions in the Asia-Pacific Region" said Dr Deborah Gleeson, spokesperson for the Public Health Association of Australia. "Now that the U.S. has withdrawn, the opportunity to remove these harmful and unnecessary rules should not be missed."
New Zealand Public Health Association President Louise Delany urged the parties ‘to ensure that health, social and
environmental objectives are central to any new agreement, so that trade rules are consistent with and help give effect
to the globally agreed Sustainable Development Goals’.
‘The TPPA was another life sentence hanging over people with HIV and AIDS. We thought that was lifted when the US pulled
out. Now some of them they want to go ahead. Listen to us. Choose life over the TPPA said Edward Low, Director of
Positive Malaysian Treatment Access & Advocacy Group (MTAAG+)’.
‘We are shocked that the TPPA, which raised grave health and human rights concerns, remains on the agenda of 11 of the
original negotiating countries, even after the US has pulled out of it. APN+ members are in 6 of these countries -
Malaysia, Vietnam, Singapore, Australia, New Zealand and Japan - and will be among the first to face the consequences of
this disastrous trade agreement on their health and lives’, said Shiba Phurailatpam of the Asia Pacific Network of
People living with HIV and AIDS (APN+). ‘We now know that the TPPA text gives stronger and greatly expanded intellectual
property rights over medicines to the multinational pharmaceutical industry that will adversely impact the lives and
health of millions of patients in the Asia-Pacific. It must be rejected - once and for all.’
Dr Deborah Gleeson Public Health Association of Australia 0423 209029
Dr Patricia Ranald Australian Fair Trade and Investment Network
0419 695 841
Open letter to Ministers of Trade from Trans-Pacific Partnership Agreement signatories meeting in Hanoi on 20-21 May
As organisations representing health professionals and health advocates from countries that are signatories to the
Trans-Pacific Partnership Agreement (TPP), we write to convey our deep concerns about reports that some of the remaining
TPP parties are considering resurrecting the TPP following the U.S. withdrawal, and to reiterate concerns raised with
you previously regarding its negative impacts on people’s right to health, access to affordable medicines, and the
ability of governments to regulate health-damaging activities of corporations.
Many of the rules and obligations in the TPP were imposed by the U.S. and are only in the interest of multinational
pharmaceutical corporations. These include a suite of intellectual property provisions that would reduce access to
medicines, including the unprecedented U.S. imposed requirement that governments guarantee at least five years’
exclusivity for biologic products. Now that the U.S. is no longer party to the agreement there is no rationale for
keeping the TPP alive and retaining these harmful elements of the agreement.
We urge you to remove these harmful provisions, and to recognise that the concerns of the health community cannot be
addressed by minor changes to the signed-on 4 February 2016 text. To address those concerns would require many parts of
the text to be rewritten from first principles. Unless these damaging provisions can be removed and comprehensive public
health safeguards can be included, we strongly believe the TPP should be rejected.
We call on the parties to the Agreement instead to enter into an open and forward-looking dialogue with the health
policy community to find a new balance that recognises the legitimate trade interests of countries, while fully
protecting the ability of sovereign governments to adopt policies and regulations for health.
International and regional
World Federation of Public Health Associations
International Treatment Preparedness Coalition Latin American and Caribbean ITPC-LATCA
Asia Pacific Network of people living with HIV and AIDS (APN+)
Public Health Association of Australia
Australian Nursing and Midwifery Federation
Centre for Health Equity Training, Research and Evaluation (CHETRE), UNSW Centre for
Primary Health Care and Equity, University of New South Wales
Foundation for Alcohol Research and Education
Australian Fair Trade and Investment Network (AFTINET)
Australian Catholic Social Justice Council
Australian Services Union
NSW Nurses and Midwives Association
Union Aid Abroad – APHEDA
Older Women's Network NSW Inc
Presentation Sisters Queensland
Canadian HIV/AIDS Legal Network.
The Global Health Equity Group
Movimiento Salud Digna (Movement for Decent/Dignified Health)
Politicas Farmaceuticas of Chile
Japan Federation of Democratic Medical InstitutionsMIN-IREN)”
Japanese Medical and Dental Practitioners for the Improvement of Medical Care (Hodanren)
Japan Federation of Medical Workers’ Unions
Malaysian AIDS Council
Positive Malaysian Treatment Access & Advocacy Group (MTAAG+)
Monitoring Sustainability of Globalisation (MSN)
Pertubuhan Islah Movement
Public Health Association of New Zealand
Association of Salaried Medical Specialists
Doctors for Healthy Trade
National Addiction Centre, University of Otago, Christchurch
New Zealand Nurses Organisation
OraTaiao: The New Zealand Climate and Health Council
Acción Internacional Para la Salud – Perú (International Action for Health – Peru)
Asociación Latinoamericana de Medicina Social – Perú (Latin American Social Medicine Association – Peru)
Colectivo Dignidad en Salud (Dignity in Health Collective)
Grupo Impulsor de la Vigilancia de Antirretrovirales (GIVAR) (Antiretroviral Surveillance Group (GIVAR))
Justicia en Salud (Justice in Health)
Programa de soporte a la Autoayuda de Personas Seropositivas (PROSA) (Self-Help Support Program for Seropositive People
Red de Pacientes y Usuarios – Perú (Patients and Users Network – Peru)
Si da Vida (If you give life)
Salud Preventiva Andina (Andean Preventive Health)
Vietnam Network of People Living with HIV/AIDS (VNP+)
Dr Patricia Ranald
Convener, Australian FairTrade and Investment Network